MIRM Competitors & Alternatives
Compare Mirum Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
MIRM
Main Stock$95.49
Tradestie Score
53
Market Cap
$3.67B
Revenue Growth
0.4%
Analyst Upside
+53.7%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$75.18
|
$6.68B | - | 61 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$86.84
|
$6.64B | - | 56 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$113.55
|
$6.38B | - | 48 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$26.98
|
$6.03B | - | 57 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$48.56
|
$6.02B | - | 56 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$99.90
|
$5.95B | - | 56 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$227.40
|
$5.92B | - | 61 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$39.48
|
$5.80B | 13.8 | 56 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$291.75
|
$5.20B | 39.5 | 65 | Compare |
More MIRM Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry